Age yrs | 29 (19–60) |
Male/female n | 48:31 |
Body mass index kg·m-2 | |
Male | 21.5 (15.4–26.0) |
Female | 19.8 (16.2–25.3) |
Presence of underlying diseases % | 24 (30.4) |
Diabetes | 8 (10.1) |
Cardiovascular disorders | 7 (8.9) |
Chronic liver diseases | 5 (6.3) |
COPD or other lung diseases | 4 (5.1) |
Number of resistant drugs | 5 (2–11) |
Resistant to neither injectables nor ofloxacin | 27 (34.2) |
Resistant to injectable | 24 (30.4) |
Resistant to ofloxacin | 10 (12.6) |
Resistant to injectable and ofloxacin | 18 (22.8) |
Duration of chemotherapy before surgery months | 14.5 (9–112) |
Persistent positive Mycobacterium tuberculosis culture before surgery | 77 (97.5) |
Number of drugs used before surgery | 6 (4–8) |
Patients receiving a regimen containing quinolones before surgery | 70 (88.6)# |
Radiographic characteristics | |
Presence of cavity | 77 (97.5) |
Presence of cavity beyond the range of resection | 28 (35.4) |
Ipsilateral to resected lung | 3 (3.8) |
Contralateral to resected lung | 25 (31.6) |
Confined to one lobe | 3 (3.8) |
Confined to one lung | 26 (32.9) |
Involvement of both lungs | 53 (67.1) |